Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC
Novo Nordisks CagriSema Shows Strong Weight-Loss Results But Trails Eli Lillys Tirzepatide in Latest Clinical Data Feb 26, 2026 A New Chapter in the Global Anti-Obesity Drug Race The competition to develop next-generation obesity therapies intensified following the release of new Phase III clinical data for CagriSema, an investigational drug from Novo Nordisk
So, more for my own resource, Im dropping Gabor in here, at least until I find the Peak Human podcast episode where he describes the anatomy of the gut and the biochemistry of gut hormones effects even more clearly: Released from cells in the proximal intestine (closer to stomach) 26252069 585 KB Released from cells in the distal intestine (further from the stomach, closer to the large bowel) 16671618 367 KB This was the podcast where I first listened about Semaglutide/ GLP-1 agonist micro-dosing
Stroke is a severe disease of cerebral blood circulation disturbance and a major public health event that results in death and disability on a global scale